小样本中的大数据:细胞病理学中二代测序的信息学
本文综述了细胞病理学中二代测序(NGS)信息学的各个方面。随着NGS在临床分子实验室的快速采用,细胞病理学已从单纯诊断工具演变为提供指导临床管理的基因组信息。综述强调需最大化利用有限细胞学样本进行辅助分子研究,细胞病理学家需参与样本采集处理并了解下游检测与信息学问题,同时需理解NGS工作流程的计算组件并建立稳健可持续的信息学基础设施。
要点
- 细胞病理学已演变为提供指导临床管理的基因组信息的实践。
- 需最大化利用有限细胞学样本进行NGS等辅助分子研究。
- 细胞病理学家需了解下游检测和信息学问题。
核心结论
- 细胞病理学实践因NGS采用而重新定义,需整合分子信息学以优化患者护理。
研究设计与样本
- 综述,检索范围未明确报告。
主要发现
- 细胞病理学已从诊断工具演变为提供基因组信息指导临床管理。
- 强调最大化利用有限细胞学样本进行NGS等辅助分子研究。
- 需理解NGS工作流程的计算组件及建立稳健信息学基础设施。
临床怎么用
- 细胞病理学家应参与样本采集和处理技术,并了解下游检测和信息学问题。
- 适应从样本获取到报告交付的需求,以优化细胞学标本利用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The rapid adoption of next-generation sequencing (NGS) in clinical molecular laboratories has redefined the practice of cytopathology. Instead of simply being used as a diagnostic tool, cytopathology has evolved into a practice providing important genomic information that guides clinical management. The recent emphasis on maximizing limited-volume cytology samples for ancillary molecular studies, including NGS, requires cytopathologists not only to be more involved in specimen collection and processing techniques but also to be aware of downstream testing and informatics issues. For the integration of molecular informatics into the clinical workflow, it is important to understand the computational components of the NGS workflow by which raw sequence data are transformed into clinically actionable genomic information and to address the challenges of having a robust and sustainable informatics infrastructure for NGS-based testing in a clinical environment. Adapting to needs ranging from specimen procurement to report delivery is crucial for the optimal utilization of cytology specimens to accommodate requests from clinicians to improve patient care. This review presents a broad overview of the various aspects of informatics in the context of NGS-based testing of cytology specimens. Cancer Cytopathol 2017;125:236-244. © 2016 American Cancer Society.
引用
- Roy-Chowdhuri S, Roy S, Monaco SE, et al. Big data from small samples: Informatics of next-generation sequencing in cytopathology. Cancer Cytopathol. 2016. PMID: 27918649. doi:10.1002/cncy.21805
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。